Osteopontin and colon cancer progression

Clinical and Experimental Metastasis

Volumn 20, Issue 1, 2003, Pages 85-90

  Yeatman, Timothy J ^a   Chambers, Ann F ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

Colon cancer; Gene expression profiling; Metastasis; Microarray; Osteopontin; Tumor progression

Indexed keywords

OSTEOPONTIN; TUMOR MARKER; WNT PROTEIN;

ANGIOGENESIS; APOPTOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CELL ADHESION; CELL GROWTH; CELL INVASION; COLON CARCINOGENESIS; COLON CARCINOMA; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; METASTASIS; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; REVIEW; SURVIVAL RATE; TUMOR GROWTH; UNINDEXED SEQUENCE;

CLUSTER ANALYSIS; COLONIC NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; OSTEOPONTIN; PROTO-ONCOGENE PROTEINS; SIALOGLYCOPROTEINS; TUMOR MARKERS, BIOLOGICAL; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0037220012     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022502805474     Document Type: Review

References (21)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
2. Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001; 1: 157-62.
3. Bos JL, Fearon ER, Hamilton SR et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293-7.
4. Irby RB, Mao W, Coppola D et al. Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 1999; 21: 187-90.
5. Baker SJ, Markowitz S, Fearon ER et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249: 912-5.
6. He TC, Sparks AB, Rago C et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-12.
7. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6.
8. Wielenga VJ, Smits R, Korinek V et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999; 154: 515-23.
9. Agrawal D, Chen T, Irby R et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 2002; 94: 513-21.
10. Moertel CG, Fleming TR, Macdonald JS et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993; 270: 943-7.
11. Brown LF, Papadopoulos-Sergiou A, Berse B et al. Osteopontin expression and distribution in human carcinomas. Am J Pathol 1994; 145: 610-23.
12. Oates AJ, Barraclough R, Rudland PS. The role of osteopontin in tumorigenesis and metastasis. Invasion Metastasis 1997; 17: 1-15.
13. Furger KA, Menon RK, Tuckl AB et al. The functional and clinical roles of osteopontin in cancer and metastasis. Curr Mol Med 2001; 1: 621-32.
14. Tuck AB, Chambers AF. The role of osteopontin in breast cancer: Clinical and experimental studies. J Mammary Gland Biol Neoplasia 2001; 6: 419-29.
15. El-Tanani MK, Barraclough R, Wilkinson MC et al. Regulatory region of metastasis-inducing DNA is the binding site for T cell factor-4. Oncogene 2001; 20: 1793-7.
16. Rudland PS, Platt-Higgins A, El-Tanani M et al. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res 2002; 62: 3417-27.
17. Sodek J, Ganss B, McKee MD. Osteopontin. Crit Rev Oral Biol Med 2000; 11: 279-303.
18. Tuck AB, Elliott BE, Hota C et al. Osteopontin-induced, integrindependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met). J Cell Biochem 2000; 78: 465-75.
19. Tuck AB, Arsenault DM, O'Malley FP et al. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene 1999; 18: 4237-46.
20. Tuck AB, Hota C, Chambers AF. Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent. Breast Cancer Res Treat 2001; 70: 197-204.
21. Denhardt DT, Noda M, O'Regan AW et al. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001; 107: 1055-61.